Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


06.11.2017

1 Acta Neurochir Suppl
1 Am Fam Physician
1 Am J Surg Pathol
2 Anticancer Res
1 Arab J Urol
1 Biomark Med
1 Biosci Trends
1 BJU Int
1 BMC Cancer
1 Cancer Cell
1 Cancer Res
1 Cell Mol Life Sci
1 Chem Res Toxicol
1 Drugs Today (Barc)
1 Environ Int
1 Eur Urol
2 Eur Urol Focus
1 Hinyokika Kiyo
1 Int J Clin Pharmacol Ther
1 Int J Urol
1 J Exp Clin Cancer Res
1 J Vet Intern Med
1 Life Sci
1 Lung India
1 Mol Med Rep
1 Nat Rev Urol
1 Occup Environ Med
1 Oncol Lett
5 Oncotarget
1 Pathol Oncol Res
1 Qual Life Res
1 Rinsho Ketsueki
1 Sci Rep
2 Urol Int
2 Urol Oncol
1 World J Urol
1 Zhongguo Zhong Yao Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurochir Suppl

  1. MAUGERI R, Graziano F, Basile L, Guli C, et al
    Reconstruction of Vertebral Body After Radiofrequency Ablation and Augmentation in Dorsolumbar Metastatic Vertebral Fracture: Analysis of Clinical and Radiological Outcome in a Clinical Series of 18 Patients.
    Acta Neurochir Suppl. 2017;124:81-86.
    PubMed     Text format     Abstract available


    Am Fam Physician

  2. DEGEORGE KC, Holt HR, Hodges SC
    Bladder Cancer: Diagnosis and Treatment.
    Am Fam Physician. 2017;96:507-514.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  3. LEIVO MZ, Sahoo D, Hamilton Z, Mirsadraei L, et al
    Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion.
    Am J Surg Pathol. 2017 Oct 26. doi: 10.1097/PAS.0000000000000964.
    PubMed     Text format     Abstract available


    Anticancer Res

  4. LIAW CC, Chuang CK, Chang YH, Liao TY, et al
    Bladder Urothelial Carcinoma with Peritoneal Involvement: Benefit of Continuous Maintenance Chemotherapy.
    Anticancer Res. 2017;37:6443-6451.
    PubMed     Text format     Abstract available

  5. HSU FT, Sun CC, Wu CH, Lee YJ, et al
    Regorafenib Induces Apoptosis and Inhibits Metastatic Potential of Human Bladder Carcinoma Cells.
    Anticancer Res. 2017;37:4919-4926.
    PubMed     Text format     Abstract available


    Arab J Urol

  6. ZAHRAN MH, Sheir K, Zidan EM, Ali-El-Dein B, et al
    Validation of the Arabic version of the Functional Assessment of Cancer Therapy-Bladder questionnaire in Egyptian patients with bladder cancer.
    Arab J Urol. 2017;15:110-114.
    PubMed     Text format     Abstract available


    Biomark Med

  7. BUTT E, Ebbing J, Bubendorf L, Ardelt P, et al
    Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma.
    Biomark Med. 2017;11:347-357.
    PubMed     Text format     Abstract available


    Biosci Trends

  8. AHN KI, Choi EO, Kwon DH, HwangBo H, et al
    Induction of apoptosis by ethanol extract of Citrus unshiu Markovich peel in human bladder cancer T24 cells through ROS-mediated inactivation of the PI3K/Akt pathway.
    Biosci Trends. 2017 Oct 24. doi: 10.5582/bst.2017.01218.
    PubMed     Text format     Abstract available


    BJU Int

  9. KINNEAR N, Smith R, Hennessey DB, Bolton D, et al
    Implementation rates of uro-oncology multidisciplinary meeting decisions.
    BJU Int. 2017;120 Suppl 3:15-20.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. MIYAKE M, Morizawa Y, Hori S, Marugami N, et al
    Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
    BMC Cancer. 2017;17:237.
    PubMed     Text format     Abstract available


    Cancer Cell

  11. ROBERTS KJ, Kershner AM, Beachy PA
    The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
    Cancer Cell. 2017;32:404-410.
    PubMed     Text format     Abstract available


    Cancer Res

  12. DUEX JE, Owens C, Chauca-Diaz A, Dancik GM, et al
    Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
    Cancer Res. 2017;77:4858-4867.
    PubMed     Text format     Abstract available


    Cell Mol Life Sci

  13. LI QQ, Hsu I, Sanford T, Railkar R, et al
    Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.
    Cell Mol Life Sci. 2017 Oct 25. doi: 10.1007/s00018-017-2681.
    PubMed     Text format     Abstract available


    Chem Res Toxicol

  14. PINK M, Verma N, Zerries A, Schmitz-Spanke S, et al
    Dose-Dependent Response to 3-Nitrobenzanthrone Exposure in Human Urothelial Cancer Cells.
    Chem Res Toxicol. 2017;30:1855-1864.
    PubMed     Text format     Abstract available


    Drugs Today (Barc)

  15. HODGKINSON L
    American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA).
    Drugs Today (Barc). 2017;53:367-369.
    PubMed     Text format     Abstract available


    Environ Int

  16. LYNCH HN, Zu K, Kennedy EM, Lam T, et al
    Corrigendum to "Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data" Environmental International 106 :178-206.
    Environ Int. 2017;109:195-196.
    PubMed     Text format    


    Eur Urol

  17. MAIA MC, Grivas P, Agarwal N, Pal SK, et al
    Circulating Tumor DNA in Bladder Cancer: Novel Applications and Future Directions.
    Eur Urol. 2017 Oct 30. pii: S0302-2838(17)30902.
    PubMed     Text format    


    Eur Urol Focus

  18. GORDON PC, Thomas F, Noon AP, Rosario DJ, et al
    Long-term Outcomes from Re-resection for High-risk Non-muscle-invasive Bladder Cancer: A Potential to Rationalize Use.
    Eur Urol Focus. 2017 Oct 28. pii: S2405-4569(17)30241.
    PubMed     Text format     Abstract available

  19. HENDRICKSEN K, Aziz A, Bes P, Chun FK, et al
    Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.
    Eur Urol Focus. 2017 Oct 23. pii: S2405-4569(17)30206.
    PubMed     Text format     Abstract available


    Hinyokika Kiyo

  20. JIKUYA R, Washimi K, Yasui M, Hashizume A, et al
    [A Case of Long Survival in Aggressively Growing Small Cell Carcinoma of the Bladder Successfully Treated by Combined Chemotherapy of Methotrexate, Etoposide and Cisplatin].
    Hinyokika Kiyo. 2017;63:245-249.
    PubMed     Text format     Abstract available


    Int J Clin Pharmacol Ther

  21. ALANEE SR, Shah S, Zabor EC, Vijai J, et al
    Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder.
    Int J Clin Pharmacol Ther. 2017;55:203-209.
    PubMed     Text format     Abstract available


    Int J Urol

  22. TAN YG, Eu EWC, Huang HH, Lau WKO, et al
    High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Nov 1. doi: 10.1111/iju.13480.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  23. ZHUANG C, Huang X, Zhuang C, Luo X, et al
    Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.
    J Exp Clin Cancer Res. 2017;36:151.
    PubMed     Text format     Abstract available


    J Vet Intern Med

  24. HENRY CJ, Flesner BK, Bechtel SA, Bryan JN, et al
    Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
    J Vet Intern Med. 2017 Oct 27. doi: 10.1111/jvim.14848.
    PubMed     Text format     Abstract available


    Life Sci

  25. HATA S, Ise K, Azmahani A, Konosu-Fukaya S, et al
    Expression of AR, 5alphaR1 and 5alphaR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
    Life Sci. 2017;190:15-20.
    PubMed     Text format     Abstract available


    Lung India

  26. AL-AMER M, Abdeen Y, Shaaban H, Alderink C, et al
    Solitary pulmonary adenofibroma in a middle-aged man with bladder cancer.
    Lung India. 2017;34:570-572.
    PubMed     Text format    


    Mol Med Rep

  27. HUHE M, Liu S, Zhang Y, Zhang Z, et al
    Expression levels of transcription factors c-Fos and c-Jun and transmembrane protein HAb18G/CD147 in urothelial carcinoma of the bladder.
    Mol Med Rep. 2017;15:2991-3000.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  28. WALSHAW RC, Honeychurch J, Illidge TM, Choudhury A, et al
    The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer.
    Nat Rev Urol. 2017 Oct 31. doi: 10.1038/nrurol.2017.
    PubMed     Text format     Abstract available


    Occup Environ Med

  29. STEENLAND K, Barry V, Anttila A, Sallmen M, et al
    A cohort mortality study of lead-exposed workers in the USA, Finland and the UK.
    Occup Environ Med. 2017;74:785-791.
    PubMed     Text format     Abstract available


    Oncol Lett

  30. SATO M, Yoneyama MS, Hatakeyama S, Funyu T, et al
    The role of LIM and SH3 protein-1 in bladder cancer metastasis.
    Oncol Lett. 2017;14:4829-4834.
    PubMed     Text format     Abstract available


    Oncotarget

  31. MAO XW, Xiao JQ, Xu G, Li ZY, et al
    CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/beta-catenin signaling pathway.
    Oncotarget. 2017;8:77241-77253.
    PubMed     Text format     Abstract available

  32. ZHAN Y, Li Y, Guan B, Wang Z, et al
    Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2.
    Oncotarget. 2017;8:76656-76665.
    PubMed     Text format     Abstract available

  33. LIU J, Gong X, Zhu X, Xue D, et al
    Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-kappaB signaling.
    Oncotarget. 2017;8:75272-75283.
    PubMed     Text format     Abstract available

  34. YIN H, Yang X, Gu W, Liu Y, et al
    HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation.
    Oncotarget. 2017;8:71642-71656.
    PubMed     Text format     Abstract available

  35. TAO T, He C, Deng J, Huang Y, et al
    A novel synthetic derivative of quercetin, 8-trifluoromethyl-3,5,7,3',4'-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway.
    Oncotarget. 2017;8:71657-71671.
    PubMed     Text format     Abstract available


    Pathol Oncol Res

  36. MITRAKAS L, Gravas S, Papandreou C, Koukoulis G, et al
    Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFkappaB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression.
    Pathol Oncol Res. 2017 Oct 28. doi: 10.1007/s12253-017-0340.
    PubMed     Text format     Abstract available


    Qual Life Res

  37. KRAJEWSKI W, Koscielska-Kasprzak K, Rymaszewska J, Zdrojowy R, et al
    How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial.
    Qual Life Res. 2017;26:625-634.
    PubMed     Text format     Abstract available


    Rinsho Ketsueki

  38. YAMADA M, Kuroda H, Sato K, Miura S, et al
    Spontaneous regression of methotrexate-related diffuse large B-cell lymphoma following bladder lesion resection.
    Rinsho Ketsueki. 2017;58:287-291.
    PubMed     Text format     Abstract available


    Sci Rep

  39. LIN YC, Lin JF, Tsai TF, Chen HE, et al
    Acridine orange exhibits photodamage in human bladder cancer cells under blue light exposure.
    Sci Rep. 2017;7:14103.
    PubMed     Text format     Abstract available


    Urol Int

  40. LONG X, Qi L, Zu X, Li Y, et al
    Prevention of Recurrent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: An Individualized Selection Strategy Based on Patient Risk Stratification Is Needed.
    Urol Int. 2017;98:312-319.
    PubMed     Text format     Abstract available

  41. WOLTERS M, Oelke M, Lutze B, Weingart M, et al
    Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs.
    Urol Int. 2017;98:268-273.
    PubMed     Text format     Abstract available


    Urol Oncol

  42. CHOUDHARY D, Clement JM, Choudhary S, Voznesensky O, et al
    SATB1 and bladder cancer: Is there a functional link?
    Urol Oncol. 2017 Oct 24. pii: S1078-1439(17)30531.
    PubMed     Text format     Abstract available

  43. NIWA N, Kikuchi E, Matsumoto K, Kosaka T, et al
    Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Guerin therapy.
    Urol Oncol. 2017 Oct 30. pii: S1078-1439(17)30535.
    PubMed     Text format     Abstract available


    World J Urol

  44. LIN T, Li K, Liu H, Xue X, et al
    Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium.
    World J Urol. 2017 Oct 28. doi: 10.1007/s00345-017-2108.
    PubMed     Text format     Abstract available


    Zhongguo Zhong Yao Za Zhi

  45. TAN DQ, Liu XH
    [Mechanism in growth inhibition of quercetin on human bladder cancer cell line].
    Zhongguo Zhong Yao Za Zhi. 2017;42:1742-1746.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: